about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...
Read More
2.21
0.00
(0.00%)
26,428
XNAS Volume
XNAS 02 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..